US5855901AExpiredUtility
Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides
Est. expiryJun 7, 2015(expired)· nominal 20-yr term from priority
Inventors:Andrew J. Malcolm
A61K 2039/6037A61K 2039/55511A61K 2039/55583A61K 47/646C07H 3/06A61K 39/092A61P 37/04A61K 39/39A61K 2039/64Y02A50/30
39
PatentIndex Score
3
Cited by
194
References
3
Claims
Abstract
The invention provides compositions comprising an oligosaccharide of S. pneumoniae serotype 8 useful for stimulating an immune response to an antigen, methods of providing protective immunization against a bacterial pathogen using these compositions, methods of augmenting an immunogenic response to an antigen by administering these S. pneumoniae serotype 8 oligosaccharide compositions along with the antigen, and methods of making the immunostimulatory compositions described above.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A composition useful for stimulating an inmune response to an antigen, said immunostimulatory composition consisting essentially of: a) an antigen, which antigen is not an oligosaccharide of S. pneumoniae serotype 8 and which antigen is not attached to an oligosaccharide of S. pneumoniae serotype 8; b) an oligosaccharide of S. pneumoniae serotype 8 which contains an immunogenic epitope; and c) a suitable pharmaceutical excipient, wherein said oligosaccharide of S. pneumoniae serotype 8 stimulates or enhances an immune response to the antigen when said composition is administered to an animal.
2. The composition of claim 1 which is suitable for administration via a route selected from the group consisting of oral and parenteral.
3. The composition of claim 1 wherein the antigen is selected from the group consisting of non-immunogenic and weakly immunogenic carbohydrates.Join the waitlist — get patent alerts
Track US5855901A — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.